Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 412

1.

Edoxaban -- Benefit Assessment According to §35a Social Code Book V [Internet].

Institute for Quality and Efficiency in Health Care.

Cologne, Germany: Institute for Quality and Efficiency in Health Care (IQWiG); 2015 Oct 28.

2.

Non-valvular atrial fibrillation: impact of apixaban on patient outcomes.

Ioannou A, Tsappa I, Metaxa S, Missouris CG.

Patient Relat Outcome Meas. 2017 Nov 3;8:121-131. doi: 10.2147/PROM.S117549. eCollection 2017. Review.

3.

Medical Treatment of Intracranial Atherosclerosis: An Update.

Kim JS, Bang OY.

J Stroke. 2017 Sep;19(3):261-270. doi: 10.5853/jos.2017.01830. Epub 2017 Sep 29. Review.

4.

Novel Anticoagulant Therapy of Venous Thromboembolism: Current Status and Future Directions.

Nakamura M, Yamada N, Ito M.

Ann Vasc Dis. 2017 Jun 25;10(2):92-98. doi: 10.3400/avd.ra.17-00015. Review.

5.

Navigating the anticoagulant landscape in 2017.

Douketis JD.

Cleve Clin J Med. 2017 Oct;84(10):768-778. doi: 10.3949/ccjm.84gr.17005. Review.

6.

Pediatric Hospital Acquired Venous Thromboembolism.

Witmer CM, Takemoto CM.

Front Pediatr. 2017 Sep 19;5:198. doi: 10.3389/fped.2017.00198. eCollection 2017. Review.

7.

Pharmacological and Non-pharmacological Treatments for Stroke Prevention in Patients with Atrial Fibrillation.

Ueberham L, Dagres N, Potpara TS, Bollmann A, Hindricks G.

Adv Ther. 2017 Oct;34(10):2274-2294. doi: 10.1007/s12325-017-0616-6. Epub 2017 Sep 27. Review.

8.

Cancer-Associated Venous Thromboembolism: A Practical Review Beyond Low-Molecular-Weight Heparins.

Smrke A, Gross PL.

Front Med (Lausanne). 2017 Aug 28;4:142. doi: 10.3389/fmed.2017.00142. eCollection 2017. Review.

9.

Hand and wrist surgery without suspending warfarin or oral antiplatelet - systematic review.

Sardenberg T, Deienno FS, Miranda RF, Varanda D, Cortopassi AC, Silvares PRA.

Rev Bras Ortop. 2017 Jul 14;52(4):390-395. doi: 10.1016/j.rboe.2017.07.001. eCollection 2017 Jun-Jul. Review.

10.

NOACs vs. Warfarin for Stroke Prevention in Nonvalvular Atrial Fibrillation.

Patel P, Pandya J, Goldberg M.

Cureus. 2017 Jun 26;9(6):e1395. doi: 10.7759/cureus.1395. Review.

11.

A systematic review of the pharmacokinetic and pharmacodynamic interactions of herbal medicine with warfarin.

Choi S, Oh DS, Jerng UM.

PLoS One. 2017 Aug 10;12(8):e0182794. doi: 10.1371/journal.pone.0182794. eCollection 2017. Review.

12.

Direct Oral Anticoagulants Use in Antiphospholipid Syndrome: Are These Drugs an Effective and Safe Alternative to Warfarin? A Systematic Review of the Literature: Comment.

Cohen H, Hunt BJ, Efthymiou M, Mackie IJ, Khamashta M, Isenberg DA; RAPS Trial Investigators.

Curr Rheumatol Rep. 2017 Aug;19(8):50. doi: 10.1007/s11926-017-0675-3. Review.

13.

Warfarin, Drug Interactions.

Crader MF, Bhimji SS.

StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2017 Jun-.
2017 Oct 6.

14.

Effects of Non-Vitamin K Antagonist Oral Anticoagulants Versus Warfarin in Patients With Atrial Fibrillation and Valvular Heart Disease: A Systematic Review and Meta-Analysis.

Pan KL, Singer DE, Ovbiagele B, Wu YL, Ahmed MA, Lee M.

J Am Heart Assoc. 2017 Jul 18;6(7). pii: e005835. doi: 10.1161/JAHA.117.005835. Review.

15.

Vitamins K1 and K2: The Emerging Group of Vitamins Required for Human Health.

Schwalfenberg GK.

J Nutr Metab. 2017;2017:6254836. doi: 10.1155/2017/6254836. Epub 2017 Jun 18. Review.

16.

Toxicity, Warfarin.

Deaton JG, Bhimji SS.

StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2017 Jun-.
2017 May 23.

17.

Maternal and Fetal Outcomes of Anticoagulation in Pregnant Women With Mechanical Heart Valves.

Steinberg ZL, Dominguez-Islas CP, Otto CM, Stout KK, Krieger EV.

J Am Coll Cardiol. 2017 Jun 6;69(22):2681-2691. doi: 10.1016/j.jacc.2017.03.605. Review.

18.

Stroke Prevention in Atrial Fibrillation: Focus on Latin America.

Massaro AR, Lip GYH.

Arq Bras Cardiol. 2016 Dec;107(6):576-589. doi: 10.5935/abc.20160116. Epub 2016 Aug 11. Review. Portuguese, English.

19.

Stroke in Patients with Chronic Kidney Disease…: How do we Approach and Manage it?

Nayak-Rao S, Shenoy MP.

Indian J Nephrol. 2017 May-Jun;27(3):167-171. doi: 10.4103/0971-4065.202405. Review.

20.

Celecoxib Therapy and CYP2C9 Genotype.

Dean L.

In: Pratt V, McLeod H, Dean L, Malheiro A, Rubinstein W, editors. Medical Genetics Summaries [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2012-.
2016 Aug 18.

Supplemental Content

Loading ...
Support Center